PD1 gene polymorphism is associated with a poor prognosis in hepatocellular carcinoma following liver resection

PD1 gene polymorphism is associated with a poor prognosis in hepatocellular carcinoma following liver resection - PD1 gene polymorphism is associated with a poor prognosis in hepatocellular carcinoma following liver resection

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000039950

Enrollment

321

Registered

2020-03-26

Start date

2018-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatocellular carcinoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The inclusion criteria were as follows: the tumor was histologically diagnosed as HCC; no distant metastasis was detected in the preoperative image; hepatectomy for HCC was conducted for the first time; and absence of any other malignancies.

Exclusion criteria

Exclusion criteria: Exclusion for above statement.

Design outcomes

Primary

Measure	Time frame
The primary end point is overall survival.	—

Countries

Japan

Contacts

Public ContactMasateru Masateru

Hiroshima University Department of Gastroenterological and Transplant Surgery

mayamamoto@hiroshima-u.ac.jp082-257-5555

Outcome results